Led by researchers at BBMRI-ERIC, the effort intends to clarify how entities should share data, including genomics information, across institutions and countries.
Participants aim to use predictive modeling to better understand epigenetic mechanisms, while encouraging the development of new technologies and therapies.
Seventeen European countries have signed a declaration to have a million genomes sequenced and shareable by 2022.
The Israeli firm recently announced the results of a multicenter study of its Bladder EpiCheck test in addition to netting €2.5 million in EU funding to develop a lung cancer assay.
The test uses changes in DNA methylation patterns for the early detection of lung cancer and is based on the same platform as the firm's bladder cancer test.
The grant money will be provided through the EC's Horizon 2020 European Innovation Council program and Bpifrance's innovation development programs.
Backed by €19 million in EU funding, the initiative, called BigData@Heart, will create a research platform that could change the way cardiovascular diseases are diagnosed and treated.
The grant is being provided under the European Commission's Horizon 2020 Research and Innovation Framework program.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
Companies are now expected to have their tests cleared by authorities for clinical use, and to bring their entire catalogs into line with the new regulations by May 2022.
The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.
The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.
Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.